Atlas Trials

Impact of Hydroxocobalamine on Outcome of Smoke Inhalation Injury Admitted to the ICU

Clinical trial NCT03558646 · COMPLETED

Trial details

NCT number
NCT03558646
Sponsor
Saint-Louis Hospital, Paris, France
Status
COMPLETED
Study type
OBSERVATIONAL
Smoke Inhalation Patients
Start date
2017-06-01
Primary completion
2018-12-31
Enrollment
739

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.